Discontinuation of anticoagulant therapy for a month in a patient with HeartMate III continuous-flow left ventricular assist device without thromboembolic events

The recommended anticoagulation regimen for continuous-flow left ventricular assist device (LVAD) systems is warfarin and aspirin with a targeted international normalized ratio (INR) of 2.0–3.0. Our patient is a 58-year-old male who underwent surgical HeartMate III continuous-flow LVAD implantation...

Descripción completa

Detalles Bibliográficos
Autores principales: Elasfar, Abdelfatah, Jalali, Kafaf, Hussein, Mohamed, AlHarbi, Ibraheem, Amoudi, Osama
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6035384/
https://www.ncbi.nlm.nih.gov/pubmed/29989026
http://dx.doi.org/10.1016/j.jsha.2017.12.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6035384/
https://www.ncbi.nlm.nih.gov/pubmed/29989026
http://dx.doi.org/10.1016/j.jsha.2017.12.002

Ejemplares similares